June 05, 2025

Can Adolescent Diets Predict Fatherhood?

New research shows fathers who improved their diet as teenagers were more likely to promote healthy eating in their children and had kids who ate more fruits and vegetables.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant

June 03, 2025

Plant Diet May Delay Myeloma Precursor Progression

First clinical trial shows high-fiber plant-based diet improves microbiome and may delay MGUS/SMM progression to multiple myeloma.

Conexiant

June 02, 2025

Exercise After Chemotherapy Improves Colorectal Cancer Survival

A long-term clinical trial found that structured exercise after colon cancer treatment improved survival outcomes and reduced recurrence rates, offering evidence to support physical activity as part of survivorship care.

Conexiant

May 31, 2025

Married People May Have Better Colorectal Cancer Outcomes, Fox Chase Cancer Center Study Shows

Namrata Vijayvergia, MD, Assistant Chief of Gastrointestinal Medical Oncology at Fox Chase Cancer Center

Fox Chase Cancer Center

May 30, 2025

Extra Boost Before Surgery Shows Promise

Tevimbra added to chemo before esophageal cancer surgery doubled complete response rates in a phase 2 trial, hinting at a future shift in standard care.

Reuters

May 21, 2025

Medical Oddities: Fingernail Selfies Spot Anemia

Tea, tech, TikTok & toxins: surprising health twists hiding in phones, roads, and skin care.

Conexiant

May 19, 2025

Roswell Park is Hiring!

Working at Roswell Park will afford you incredible opportunities to work alongside some of the nation’s foremost clinicians and researchers to broaden your career experiences and be part of a team that eases the burden of cancer.

Roswell Park Comprehensive Cancer Center

May 02, 2024

AACR 2024: Adagrasib Plus Cetuximab in KRAS G12C–Mutated Colorectal Cancer

The combination of adagrasib and cetuximab may show clinical activity and promising survival outcomes in patients with metastatic, heavily pretreated, KRAS G12C–mutated colorectal cancer.

Conexiant